VYVANSE Trademark

Trademark Overview

On Monday, November 6, 2006, a trademark application was filed for VYVANSE with the United States Patent and Trademark Office. The USPTO has given the VYVANSE trademark a serial number of 77037206. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, April 14, 2018. This trademark is owned by Shire LLC. The VYVANSE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations acting on the central nervous system

Providing medical information in the field of pharmaceutical products and services
vyvanse

General Information

Serial Number77037206
Word MarkVYVANSE
Filing DateMonday, November 6, 2006
Status800 - REGISTERED AND RENEWED
Status DateSaturday, April 14, 2018
Registration Number3468580
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system
Goods and ServicesProviding medical information in the field of pharmaceutical products and services
Translation of Words in Mark"VYVANSE" appearing in the mark has no significance in the relevant trade or industry or, no geographical significance, nor any meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 9, 2006
Primary Code005
First Use Anywhere DateMonday, June 4, 2007
First Use In Commerce DateMonday, June 4, 2007
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 9, 2006
Primary Code044
First Use Anywhere DateMonday, June 4, 2007
First Use In Commerce DateMonday, June 4, 2007

Trademark Owner History

Party NameTAKEDA PHARMACEUTICALS U.S.A., INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421
Party NameShire LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFlorence, KY 41042
Party NameShire LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFlorence, KY 41042
Party NameShire LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFlorence, KY 41042

Trademark Events

Event DateEvent Description
Wednesday, September 16, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 14, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, April 14, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, April 14, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, April 14, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 3, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, July 15, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 3, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, June 3, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 17, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, June 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 17, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Monday, June 9, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 6, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 6, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 5, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 6, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 6, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 5, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 22, 2008NON-FINAL ACTION MAILED
Thursday, May 22, 2008SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 23, 2008STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 2, 2008USE AMENDMENT FILED
Wednesday, April 2, 2008PAPER RECEIVED
Tuesday, October 2, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 20, 2007EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, July 5, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 5, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2007NOTICE OF PUBLICATION
Friday, April 6, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 6, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 5, 2007ASSIGNED TO LIE
Thursday, April 5, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 5, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 5, 2007ASSIGNED TO LIE
Friday, March 2, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 1, 2007FINAL REFUSAL E-MAILED
Thursday, March 1, 2007FINAL REFUSAL WRITTEN
Thursday, March 1, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 14, 2006NON-FINAL ACTION E-MAILED
Thursday, December 14, 2006NON-FINAL ACTION WRITTEN
Thursday, December 14, 2006ASSIGNED TO EXAMINER
Thursday, November 9, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

vyvanse pharmaceutical information field products services medical system preparations acting central